These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8556729)

  • 1. Amantadine treatment of a patient with anoxic brain injury.
    Edby K; Larsson J; Eek M; von Wendt L; Ostergård B
    Childs Nerv Syst; 1995 Oct; 11(10):607-9. PubMed ID: 8556729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amantadine for the agitated head-injury patient.
    Chandler MC; Barnhill JL; Gualtieri CT
    Brain Inj; 1988; 2(4):309-11. PubMed ID: 3203176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dopaminergic agents, COMT inhibitors or amantadine? Proper treatment for your Parkinson patient].
    Ceballos-Baumann AO
    MMW Fortschr Med; 2002 May; Suppl 2():37-43. PubMed ID: 12070848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys.
    Blanchet PJ; Konitsiotis S; Chase TN
    Mov Disord; 1998 Sep; 13(5):798-802. PubMed ID: 9756148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current medical treatment of Parkinsonian syndromes].
    Cincă I; Bulandra R; Serbănesco A; Ninosu N
    Rev Roum Neurol; 1973; 10(4):257-85. PubMed ID: 4767886
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical spectrum of secondary parkinsonism in childhood: a reversible disorder.
    Pranzatelli MR; Mott SH; Pavlakis SG; Conry JA; Tate ED
    Pediatr Neurol; 1994 Mar; 10(2):131-40. PubMed ID: 8024661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current treatment of Parkinsonian syndrome].
    Lechner H; Bertha G; Ott E
    Med Welt; 1980 Oct; 31(40):1444-6. PubMed ID: 7464500
    [No Abstract]   [Full Text] [Related]  

  • 8. Changing interactions between bipolar affective disorder and anoxic brain damage.
    Collins MN; Jacobson RR
    Br J Psychiatry; 1990 May; 156():736-40. PubMed ID: 2095953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amantadine and other antiglutamate agents: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S13-22. PubMed ID: 12211136
    [No Abstract]   [Full Text] [Related]  

  • 10. Unexpected improvement after prolonged post-traumatic vegetative state.
    Arts WF; van Dongen HR; Meulstee J
    Acta Neurochir Suppl (Wien); 1988; 44():78-9. PubMed ID: 3223373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring the effect of amantadine in chronic anoxic minimally conscious state.
    Schnakers C; Hustinx R; Vandewalle G; Majerus S; Moonen G; Boly M; Vanhaudenhuyse A; Laureys S
    J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):225-7. PubMed ID: 18202217
    [No Abstract]   [Full Text] [Related]  

  • 12. [Successful use of amantadine in treatment of malignant neuroleptic syndrome].
    Blümlein G
    Psychiatr Prax; 1997 Sep; 24(5):257-8. PubMed ID: 9417555
    [No Abstract]   [Full Text] [Related]  

  • 13. Dyskinesias induced by subthalamotomy in Parkinson's disease are unresponsive to amantadine.
    Merello M; Perez-Lloret S; Antico J; Obeso JA
    J Neurol Neurosurg Psychiatry; 2006 Feb; 77(2):172-4. PubMed ID: 16421117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the synchronizing effect of amantadine-1-hydrochlorid (Symmetrel) on pathological EEG-activity.
    Vardi J; Streifler M
    J Neural Transm; 1975; 37(1):73-80. PubMed ID: 1159416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amantadine hydrochloride.
    Hinkle JL
    J Neurosci Nurs; 1991 Apr; 23(2):80. PubMed ID: 1831476
    [No Abstract]   [Full Text] [Related]  

  • 16. After traumatic brain injury: a discussion of consequences.
    Stratton MC; Gregory RJ
    Brain Inj; 1994 Oct; 8(7):631-45. PubMed ID: 7804300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind study of amantadine hydrochloride versus benztropine mesylate in drug-induced parkinsonism.
    Kelly JT; Zimmermann RL; Abuzzahab FS; Schiele BC
    Pharmacology; 1974; 12(2):65-73. PubMed ID: 4610599
    [No Abstract]   [Full Text] [Related]  

  • 18. [Corneal toxicity due to amantadine].
    Avendaño-Cantos EM; Celis-Sánchez J; Mesa-Varona D; Gálvez-Martínez J; López-Arroquia E; González Del Valle F
    Arch Soc Esp Oftalmol; 2012 Sep; 87(9):290-3. PubMed ID: 22824648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dropped head associated with amantadine in Parkinson disease.
    Kataoka H; Ueno S
    Clin Neuropharmacol; 2011; 34(1):48-9. PubMed ID: 21242745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Initial symptomatology of Parkinson disease].
    Fuhr P; Maritz D; Bernatik J; Steck AJ
    Schweiz Arch Neurol Psychiatr (1985); 1995; 146(4):175-9. PubMed ID: 8533059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.